Amy Abernethy’s Post

On this day in 1941, Pioneer of blood plasma research, Dr Charles Richard Drew, establishes a pioneer blood bank in New York City. #Surgeon #Scientist #Educator#AfricanAmerican #BloodBanks #BloodPlasma #RedCross Charles Richard Drew (June 3, 1904 – April 1, 1950) was an American surgeon and medical researcher. He researched in the field of blood transfusions, developing improved techniques for blood storage, and applied his expert knowledge to developing large-scale blood banks early in World War II. This allowed medics to save thousands of Allied forces' lives during the war. As the most prominent African American in the field, Drew protested against the practice of racial segregation in the donation of blood, as it lacked scientific foundation, and resigned his position with the American Red Cross, which maintained the policy until 1950. Drew was born in 1904 into an African-American middle-class family in Washington, D.C. His father, Richard, was acarpet layerand his mother, Nora Burrell, trained as a teacher. Drew and three (two sisters, one brother) of his four younger siblings (three sisters and one brother total) grew up in Washington's largely middle-class and interracial Foggy Bottom neighborhood. From a young age Drew began work as a newspaper boy in his neighborhood, daily helping deliver over a thousand newspapers to his neighbors. Drew attended Washington's Dunbar High School which was well known for its equality and opportunities for all, despite the racial climate at the time. From 1920 until his marriage in 1939, Drew's permanent address was in Arlington County, Virginia,malthough he graduated from Washington's Dunbar High School in 1922 and resided elsewhere during that period of time. Drew won an athletics scholarship to Amherst College in Massachusetts, where he played on the football as well as the track and field team, and later graduated in 1926. After college, Drew spent two years (1926–1928) as a professor of chemistry and biology, the first athletic director, and football coach at the historically black private Morgan College in Baltimore, Maryland, to earn the money to pay for medical school. For his medical career Drew applied to Howard University, Harvard Medical School and later McGill University. Drew lacked some prerequisites for Howard University, and Harvard wanted to defer him a year, so to begin medical school promptly, Drew decided to attend McGill's medical school in Montreal, Canada.

In December 2023, longtime UAB supporter Marnix E. Heersink, M.D., committed an additional $5 million to his transformational $95 million gift that named the UAB Marnix E. Heersink School of Medicine in 2021, bringing the total naming gift to $100 million. The gift, which also named the Marnix E. Heersink Institute of Biomedical Innovation and the Mary Heersink Institute for Global Health, was already the single largest philanthropic commitment in university history, and it will now have even greater impact. Read the story here: https://lnkd.in/eBmDqHgV

🌟Harnessing the power of scientific collaboration to drive life-changing innovations for the CF community! 🌟 We are thrilled to announce that we’ve awarded $859,932 in our ✨first ever ✨Collaborative Research Grant to researchers at University of Iowa Roy J. and Lucille A. Carver College of Medicine, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, and University of Rochester School of Medicine and Dentistry to support their important work focused on improving how CF therapeutics are delivered effectively to airway cells. Led by Paul McCray, MD, Beverly Davison, PhD, and John Lueck, PhD, this groundbreaking project will use advanced AAV capsid variants to develop targeted therapies for people with #CysticFibrosis. We are incredibly proud to support this cutting-edge research that holds the potential to provide curative treatments for all people with CF, including those in the final 10% who do not benefit from current therapies. Learn more: https://bit.ly/3KlYdlq #CureCF #RearchGrants #CysticFibrosisResearch #CFresearch

We're proud to introduce Marcee Wilder, M.D., M.S., M.P.H, one of our NIH FIRST Faculty Scholars at IHER! Learn more about the Mount Sinai NIH FIRST Program: https://lnkd.in/grfiYdbD.     Dr. Wilder is an Assistant Professor of Emergency Medicine and Population Health Science and Policy. Her research focuses on social determinants of health and the assessment of disparities in blood pressure control among Medicaid and uninsured patients.    Notably, Dr. Wilder has authored several impactful publications, including:  • "Racial Disparities in the Treatment of Acute Overdose in the Emergency Department": https://lnkd.in/etA2CXh4   • "The Impact of Social Determinants of Health on Medication Adherence: A Systematic Review and Meta-analysis": https://lnkd.in/e8pR3ejf   • "Relationship Between Social Determinants of Health and Antihypertensive Medication Adherence in a Medicaid Cohort": https://lnkd.in/eg7Zpffz     We're thrilled to spotlight Dr. Wilder's work, which deepens our understanding of health disparities and the work needed to address them. 👏    #IHER #NIHFIRST #EquityResearch #HealthDisparitiesResearch #SDOH

Learn more about the L.S. Skaggs Institute for Health Innovation (SIHI) in the University of Montana's Vision Magazine!

Dear Distinguished Professional, Warm greetings to you from me an ambassador for CMDA.It will interest you to know that the world has been in chaos in the past three years. From pandemic to wars. These events have in no small way impacted our lives and career both in perspective, priorities and practices.General, common perspectives range from political to economic and so on. For CMDA, there is always a professional perspective and a kingdom/ eschatological perspective to these occurrences.Nonetheless, we know our God gives wisdom in the midst of every circumstance such that like the children of Issachar, we can, by divinely-given understanding, discern the times and seasons and know precisely what we ought to do and how as health care professionals we should position ourselves. This conference is certainly a professional conversation and more career focused that anything else. We would be gleaning from the wisdom of someone who has gone ahead, having survived decades of highs and lows, troughs and crests both within the context of professional practice and beyond. The theme for this conference is *"WISDOM KEYS FOR CAREER SUCCESS AMIDST GLOBAL AND LOCAL CRISIS"**Monday, January 22, 2024**Via zoom**Time: 5pm AST*A little about our Guest speaker:*_Paul W. Hruz* _is an academic pediatric endocrinologist (hormone specialist) and tenured physician scientist with faculty appointments in both Pediatrics and Cellular Biology and Physiology at Washington University in St Louis. He received his MD and PhD degrees from the Medical College of Wisconsin. He completed residency training in Pediatrics at the University of Washington in Seattle and fellowship training in pediatric endocrinology at Washington University.__Dr. Hruz also has over 20 years of clinical experience in caring for children with disorders of sexual development. He has received certification in Healthcare Ethics from the National Catholic Bioethics Center and is a regular contributor to his University's course on Research Ethics for graduate students.__He has authored over 60 peer-reviewed manuscripts, scientific reviews and book chapters._Again, it is my pleasure to invite you to this great conference, our first this year.Learn more about CMDA www.cmda.org

Sharing personal connections to work is always an interesting experience. This past year marked the 20th anniversary of my recovery from Stage IV lymphoma. Those experiences long ago relate directly to the work I am doing today and you can find those ideas here in one of our most read posts from Harvard Medical School Corporate Learning. Curious to hear how your life experiences connect to your work. Certain there are many important lessons to share. https://lnkd.in/ekPQsXhw

In 2023, the University of Pennsylvania (UPenn) secured over 1,300 grants totaling over $703 million from the National Institutes of Health (NIH), elevating its national ranking to third place. This marked a significant improvement from its previous fifth-place position in 2022, surpassing the University of Pittsburgh and Duke University. NIH awards to UPenn increased 5.2% year over year and 37.5% since 2018, far exceeding the growth rates of both Johns Hopkins University (25.0%) and the University of California San Francisco (21.8%). Internal Medicine at UPenn received the largest share (27%) of non-R&D contract NIH grants awarded to the university in 2023, securing $153 million, followed by Radiation-Diagnostic/Oncology projects securing $47 million. Despite headwinds in the industry, NIH funding will continue drive the life sciences market forward in Philadelphia, as commercialization of research performed at UPenn and other prestigious universities will be a sources of potential demand for specialized facilities.